Showing results (31-40 of 326) with videos related to
Sort By:
Pageof 33
Thrombosis and Haemostasis|August 14, 2018
Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation StudyCéline Chauleur, Jean-Christophe Gris, Silvy Laporte, et al.Journal of Thrombosis and Haemostasis : JTH|April 17, 2020
Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolismJudith Catella, Laurent Bertoletti, Patrick Mismetti, et al.Critical Care Medicine|January 20, 2010
Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment modelSilvy Laporte, Patrick MismettiCirculation|December 16, 2004
Preventing venous thromboembolism in medical patientsAlain Leizorovicz, Patrick MismettiFrontiers in Immunology|February 21, 2022
Platelets as Key Factors in Inflammation: Focus on CD40L/CD40Fabrice Cognasse, Anne Claire Duchez, Estelle Audoux, et al.Revue Medicale Suisse|March 15, 2014
[New oral anticoagulants: pharmacological data to know for clinical practice]Xavier Delavenne, Silvy Laporte, Patrick MismettiPresse Medicale (Paris, France : 1983)|February 6, 2007
[Meta-analyses or megatrials: same level of proof?]Patrick Mismetti, Michel Cucherat, Silvy LaporteCurrent Opinion in Pulmonary Medicine|October 29, 2024
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?David Jiménez, Laurent Bertoletti, Behnood BikdeliPresse Medicale (Paris, France : 1983)|May 10, 2017
After deep vein thrombosis, which patients refer to vascular specialist for anticoagulant withdrawal? A Delphi study results between general practitioners and vascular specialistsAntonin Zoubian, Laurent Bertoletti, Paul FrappéHamostaseologie|July 30, 2020
Use of Anticoagulants in Patients with Pulmonary HypertensionLaurent Bertoletti, Valentine Mismetti, George GiannakoulasPageof 33